ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 258 filers reported holding ACCELERON PHARMA INC in Q4 2020. The put-call ratio across all filers is 0.78 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $16,030,000 | +95.5% | 93,147 | +42.6% | 0.01% | +125.0% |
| Q2 2021 | $8,198,000 | -4.6% | 65,335 | +3.1% | 0.00% | 0.0% |
| Q1 2021 | $8,597,000 | -3.5% | 63,394 | -9.0% | 0.00% | 0.0% |
| Q4 2020 | $8,910,000 | +9.7% | 69,646 | -3.5% | 0.00% | -20.0% |
| Q3 2020 | $8,121,000 | +4.6% | 72,172 | -11.4% | 0.01% | -16.7% |
| Q2 2020 | $7,762,000 | +14.2% | 81,465 | +7.7% | 0.01% | 0.0% |
| Q1 2020 | $6,798,000 | +134.2% | 75,633 | +38.1% | 0.01% | +200.0% |
| Q4 2019 | $2,903,000 | -65.1% | 54,764 | -74.0% | 0.00% | -71.4% |
| Q3 2019 | $8,327,000 | +218.3% | 210,740 | +230.7% | 0.01% | +250.0% |
| Q2 2019 | $2,616,000 | +18.2% | 63,717 | +34.1% | 0.00% | 0.0% |
| Q1 2019 | $2,214,000 | -5.5% | 47,517 | -11.7% | 0.00% | 0.0% |
| Q4 2018 | $2,343,000 | +16.0% | 53,827 | +52.5% | 0.00% | 0.0% |
| Q3 2018 | $2,020,000 | +2.9% | 35,298 | -12.9% | 0.00% | 0.0% |
| Q2 2018 | $1,964,000 | -2.4% | 40,504 | -21.3% | 0.00% | 0.0% |
| Q1 2018 | $2,012,000 | +25.2% | 51,468 | +36.0% | 0.00% | +100.0% |
| Q4 2017 | $1,607,000 | -52.1% | 37,844 | -57.9% | 0.00% | -66.7% |
| Q3 2017 | $3,357,000 | -17.5% | 89,972 | -32.8% | 0.00% | -25.0% |
| Q2 2017 | $4,068,000 | +2.4% | 133,874 | -10.8% | 0.00% | 0.0% |
| Q1 2017 | $3,974,000 | +3.0% | 150,131 | -0.7% | 0.00% | 0.0% |
| Q4 2016 | $3,858,000 | -48.4% | 151,163 | -26.8% | 0.00% | -42.9% |
| Q3 2016 | $7,478,000 | -43.5% | 206,619 | -47.0% | 0.01% | -53.3% |
| Q2 2016 | $13,240,000 | +255.9% | 389,653 | +176.6% | 0.02% | +275.0% |
| Q1 2016 | $3,720,000 | -17.4% | 140,878 | +52.5% | 0.00% | -20.0% |
| Q4 2015 | $4,503,000 | +100.0% | 92,360 | +2.1% | 0.01% | +66.7% |
| Q3 2015 | $2,252,000 | -39.6% | 90,422 | -23.2% | 0.00% | -25.0% |
| Q2 2015 | $3,727,000 | -9.8% | 117,795 | +8.5% | 0.00% | 0.0% |
| Q1 2015 | $4,130,000 | +5.7% | 108,524 | +8.3% | 0.00% | +33.3% |
| Q4 2014 | $3,907,000 | +392.7% | 100,243 | +282.4% | 0.00% | +200.0% |
| Q3 2014 | $793,000 | -41.4% | 26,214 | -34.2% | 0.00% | 0.0% |
| Q2 2014 | $1,354,000 | +267.9% | 39,856 | +273.0% | 0.00% | – |
| Q1 2014 | $368,000 | +77.8% | 10,684 | +104.3% | 0.00% | – |
| Q4 2013 | $207,000 | – | 5,229 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co IV LLC | 1,480,060 | $53,563,000 | 85.86% |
| NEXTHERA CAPITAL LP | 217,817 | $7,883,000 | 4.84% |
| Novo Holdings A/S | 903,833 | $32,710,000 | 2.90% |
| SECTORAL ASSET MANAGEMENT INC | 481,765 | $17,435,000 | 1.71% |
| Perceptive Advisors | 589,890 | $21,348,000 | 1.38% |
| RA Capital Management | 318,565 | $11,529,000 | 1.19% |
| OAK RIDGE INVESTMENTS LLC | 1,226,468 | $44,386,000 | 1.15% |
| Granahan Investment Management | 817,149 | $29,573,000 | 0.97% |
| Eventide Asset Management | 428,900 | $15,522,000 | 0.95% |
| QVT Financial LP | 636,764 | $23,044,000 | 0.87% |